749P ANV419, a selective IL-2R-beta-gamma targeted antibody-IL-2 fusion protein, in patients with advanced solid tumors, a phase I/II study
| Autor: | Läubli, H., Alonso, G., Lopez, J.S., Calvo, E., Joerger, M., Perez, V., Di Blasi, D., Nair, A., Richter, K., Huber, C., Mouton, J., Costanzo, S., Jethwa, S., Bucher, C.M., Garralda, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S886-S887 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|